In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations
The SARS-CoV-2 targets were evaluated for a set of FDA-approved drugs using a combination of drug repositioning and rigorous computational modeling methodologies such as molecular docking and molecular dynamics (MD) simulations followed by binding free energy calculations. Six FDA-approved drugs inc...
Main Authors: | Wesam S. Qayed, Rafaela S. Ferreira, José Rogério A. Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/18/5988 |
Similar Items
-
Snail protein inhibition by drug repositioning for recurrent breast cancer: an in-silico study
by: M. Benguella-Benmansour, et al.
Published: (2023-05-01) -
Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2
by: Matheus V.C. Grahl, et al.
Published: (2021-01-01) -
Molecular docking study of anti-viral FDA-approved drugs as novel entry and replication Ebola viral inhibitors
by: Saghi Sepehri, et al.
Published: (2019-04-01) -
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
by: Sungpil Yoon, et al.
Published: (2021-03-01) -
Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from <i>Entamoeba histolytica</i> and <i>Giardia lamblia</i> Identifies Inhibitors of Their Trophozoite Growth Phase
by: Alfredo Juárez-Saldivar, et al.
Published: (2021-05-01)